Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
907,8 INR | +3,26 % | +8,39 % | -2,53 % |
Resumen de negocios
Número de empleados: 12 220
Ventas por actividad
INR en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Financing
100,0
%
| 72 927 | 52,1 % | 90 867 | 100,0 % | +24,60 % |
Ventas por región
INR en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
India
100,0
%
| 85 413 | 61,0 % | 90 867 | 100,0 % | +6,39 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Rupen Jhaveri
PSD | President | - | 01/12/21 |
Vivek Valsaraj
PSD | President | 51 | - |
Goel Upma
DFI | Director of Finance/CFO | - | 18/08/22 |
Bipin Singh
CMP | Compliance Officer | 56 | 30/07/19 |
Viral Gandhi
CTO | Chief Tech/Sci/R&D Officer | 50 | - |
Director/Board Member | 65 | 01/08/99 | |
Director/Board Member | 43 | 01/04/09 | |
Hitesh Dhaddha
IRC | Investor Relations Contact | - | - |
S. K. Honnesh
LAW | General Counsel | - | - |
Corporate Secretary | 66 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 39 | 12/05/17 | |
Chairman | 68 | - | |
Director/Board Member | 65 | 01/08/99 | |
Shikha Sharma
BRD | Director/Board Member | 64 | 31/03/22 |
Director/Board Member | 51 | 07/10/21 | |
Kunal Bahl
BRD | Director/Board Member | 40 | 14/10/20 |
Anjali Bansal
BRD | Director/Board Member | 53 | 19/11/20 |
Director/Board Member | 63 | 10/02/22 | |
Rajiv Mehrishi
BRD | Director/Board Member | - | 26/05/22 |
- | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 224 680 093 | 114 551 387 ( 50,98 %) | 1 124 051 ( 0,5003 %) | 50,98 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
PIRAMAL PHARMA LIMITED 0.82% | 10 834 462 | 0.82% | 16 744 878 $ |
Información de la empresa
Piramal Enterprises Ltd.
Piramal Ananta, LBS Marg Agastya Corporate Park
400070, Mumbai
+91 22 3802 3000
http://www.piramal.comEmpresas del grupo
Nombre | Categoría y sector |
---|---|
Piramal Fund Management Pvt Ltd.
Piramal Fund Management Pvt Ltd. Investment ManagersFinance Piramal Fund Management Pvt Ltd. (Piramal FM) is the private equity and venture capital subsidiary of Piramal Enterprises Ltd. (BSE: 500302) in India. Led by entrepreneur-turned-professional, Mr. Ramesh Jogani, Piramal FM is backed by extensive team experience and a developer's perspective in selecting projects with an inherent assurance of delivery and successful implementation. Established in 2006, the firm advises over USD 450 Million and has invested across various real estate projects in Mumbai, Chennai, Bangalore, Hyderabad and Pune. Piramal FM is headquartered in Mumbai and provides investors with access to their understanding of Indian real estate and their network of partners. |
Investment Managers
|
PHI Fininvest Pvt Ltd.
PHI Fininvest Pvt Ltd. Financial ConglomeratesFinance PHI Fininvest Pvt Ltd. provides financial intermediation services. The company is headquartered in Mumbai, India. |
Financial Conglomerates
|
Piramal Systems & Technologies Pvt Ltd.
| |
Piramal Finance Pvt Ltd.
Piramal Finance Pvt Ltd. Real Estate DevelopmentFinance Piramal Finance Pvt Ltd. provides financial services to business of real estate. The company is headquartered in Mumbai, India. |
Real Estate Development
|
Convergence Chemicals Pvt Ltd.
Convergence Chemicals Pvt Ltd. Chemicals: SpecialtyProcess Industries Convergence Chemicals Pvt Ltd. develops and manufactures specialty fluorochemicals, primarily starting material . The company was founded in November 2014 and is headquartered in Bharuch, India. |
Chemicals: Specialty
|
Piramal Consumer Products Pvt Ltd.
Piramal Consumer Products Pvt Ltd. Investment ManagersFinance Piramal Consumer Products Pvt Ltd. operates as a consumer product division of Piramal Enterprise's Healthcare. It invests and acquires pharmaceuticals and cosmetic products producer firms. The company was founded on July 18, 2012 and is headquartered in Mumbai, India. |
Investment Managers
|
DRG Analytics & Insights Pvt Ltd.
| |
Pharmaceuticals: Major
| |
Piramal Asset Management Pvt Ltd.
|
Sector
Ventas por actividad
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-2,53 % | 2370,36 M | |
-0,45 % | 54,36 mil M | |
-1,79 % | 31,45 mil M | |
+64,11 % | 29,12 mil M | |
+19,77 % | 24,14 mil M | |
+15,00 % | 18,07 mil M | |
-8,38 % | 11,79 mil M | |
+21,50 % | 11,1 mil M | |
-25,58 % | 8029,33 M | |
+12,11 % | 7915,85 M |
- Bolsa de valores
- Acciones
- Acción PEL
- Empresa Piramal Enterprises Limited